4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia

Gotho Geishofer, Alexander Binder, Martin Müller, Bettina Zöhrer, Bernhard Resch, Wilhelm Müller, Jörg Faber, Adam Finn, Georg Endler, Christine Mannhalter, Werner Zenz*, Bärbel Töpke, Peter Fucik, Johann M. Penzien, Gedeon Diab, Robert Miething, K. H. Deeg, Jürg Hammer, Ulrich Heininger, Verena VarnholtAndreas Schmidt, Lutz Bindl, Ursula Sillaber, Christian Huemer, Primrose Meier, G. Simic-Schleicher, Markus Markart, Eberhard Pfau, Hans Broede, Bernd Ausserer, Hermann Kalhoff, Volker Arpe, Susanne Schweitzer-Krantz, Johannes Martin Kasper, Kathrin Loranth, Hans J. Bittrich, Burkhard Simmer, Nicola Weigand, Egbert Herting, Karl Heinz Smolle, Christoph Fusch, Alois Gruber, Ulf Schimmel, Suzanne Knaufer-Schiefer, Wolfgang Lässig, Axel Hennenberger, Axel Von Der Wense, Roland Tillmann, Jürgen Schwarick, F. C. Sitzmann, Herbert Müller, Peter Kurnik, Peter Groneck, Helene Gröblacher-Roth, Jürgen Bensch, Reinhard Moser, Rudolf Schwarz, Kurt Lenz, Thomas Hofmann, Wolfgang Göpel, Thomas Berger, Erwin Hauser, Kai Martin Förster, Jochen Peters, Thomas Nicolai, Björn Kumlien, Regina Beckmann, Christiane Seitz, D. Hüseman, Roland Schürmann, Van Hop Ta, Eckart Weikmann, W. Evert, Jürgen Hautz, Jürgen Seidenberg, Lucia Wocko, Petra Luigs, Hans Ludwig Reiter, J. Quietzach, Michael König, Johanna Herrmann, Horst Mitter, Ekkehard Seidler, Bernhard Maak, Wolfgang Sperl, Manfred Meissl, Reinhard Koch, Manfred Cremer, H. A. Breuer, W. Görke, Robert Nossal, Walter Pernice, Hans R. Salzer, Hartmut Koch, Gerhard Schaller, Franz Paky, Friedrich Straßer, Franz Eitelberger, D. Sontheimer, Andreas Lischka, Alfred Dilch, Christian Scheibenpflug, Robert Bruckner, Klaus Runge, Wolfgang Kunze, Peter Schermann

*Corresponding author for this work
59 Citations (Scopus)

Abstract

Meningococcal disease may present as sepsis, meningitis or a combination of both. Impaired fibrinolysis and massive elevation of the plasminogen activator inhibitor-1 (PAI-1) is a characteristic feature of meningococcal sepsis. Previously, an association between mortality and the functional 4G/5G promoter polymorphism of the PAI-1gene in a cohort of UK and Dutch children with meningococcal sepsis was reported. We carried out a prospective, multicentre study to investigate the association of the 4G/5G PAI-1 polymorphism, diagnosis, and outcome in meningococcal disease in a Central European and UK population. Blood samples and clinical information of 347 previously healthy children with meningococcal infection were collected from 95 paediatric hospitals in Germany, Switzerland, Italy, the United Kingdom, and Austria from 2000 until 2002. Mortality was significantly associated with the 4G/4G genotype (12 of 90 (13%) vs. 15 of 240 (6%), P =0.037), resulting in an odds ratio of 2.31. The diagnosis of sepsis (independent of symptoms of meningitis) was significantly more frequent in carriers of the 4G/4G genotype (P =0.01), resulting in an odds ratio of 2.21 to develop sepsis. Meningitis was not associated with the PAI-1 4G/5G polymorphism, and allele frequencies were similar in patient and control groups. Conclusion:Our data show a correlation between the 4G/4G genotype in the plasminogen activator inhibitor-1 gene and poor outcome in children with meningococcal infection. In addition, 4G homozygous patients were prone to develop sepsis. We found no influence of the plasminogen activator inhibitor-1 polymorphism on the susceptibility to invasive meningococcal infection.

Original languageEnglish
JournalEuropean Journal of Pediatrics
Volume164
Issue number8
Pages (from-to)486-490
Number of pages5
ISSN0340-6199
DOIs
Publication statusPublished - 07.2005

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of '4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia'. Together they form a unique fingerprint.

Cite this